Floatz logo

Letrozole

Migraine

Mayo ClinicSmall moleculePhase 3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
73/ 100

Competitive context

77 Active assets in the Migraine cohort.

Asset / SponsorPhaseRating
Zolmitriptan
Zosano Pharma Corporation
Phase 4A
Rizatriptan
Antonios Likourezos
Phase 4A
Treximet®
IRCCS San Raffaele Roma
Phase 4BBB
Eptinezumab
Stanford University
Phase 4BBB
mk-1602
H. Lundbeck A/S
Phase 4BBB

View all 50 →

Same molecule, other indications

Letrozole is also rated in:

infertility disorderDormant
BBB
Indicative ·
79 / 100
View asset →
anovulationDormant
BBB
Indicative ·
78 / 100
View asset →
Diabetes MellitusDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →